✦ LIBER ✦

PMH22 HOSPITALIZATION AND MEDICATION USE IN SCHIZOPHRENIA PATIENTS RECEIVING RISPERIDONE LONG-ACTING INJECTABLE OR ORAL ATYPICAL ANTIPSYCHOTIC MEDICATION

✍ Scribed by P Chue; A Lam; K Chandra; D Luong; F Camacho

Book ID: 118608037
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 63 KB
Volume: 8
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)67768-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMH23 IMPACT OF RISPERIDONE LONG-ACTING

PMH23 IMPACT OF RISPERIDONE LONG-ACTING INJECTABLE ON HOSPITALIZATION AND MEDICATION USE IN PATIENTS WITH SCHIZOPHRENIA

✍ L Beauclair; A Lam; J McCormick; D Luong; F Camacho 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

PMH67 ORAL SUPPLEMENTATION AND CONCOMITA

PMH67 ORAL SUPPLEMENTATION AND CONCOMITANT MEDICATION IN THE TREATMENT OF SCHIZOPHRENIA WITH LONG-ACTING ATYPICAL ANTIPSYCHOTICS

✍ H Ascher-Svanum; X Peng; W Montgomery; DE Faries; AH Lawson; M Witte; D Novick; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

PMH6 Effectiveness of Long-Acting Iinjec

PMH6 Effectiveness of Long-Acting Iinjectable Risperidone and Oral Atypical Antipsychotics in a 24-Months Observational Study in Adult Patients with Schizophrenia in Germany

✍ L. Hargarter; J. Fleischmann; J. Diels; J. Rabinowitz; M. Hemels; M. Gaudig; S. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Effects of switching to long-acting inje

Effects of switching to long-acting injectable risperidone from oral atypical antipsychotics on cognitive function in patients with schizophrenia

✍ Sung-Wan Kim; Il-Seon Shin; Jae-Min Kim; Seung-Hyun Lee; Yo-Han Lee; Su-Jin Yang 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

## Abstract ## Objective To investigate changes in cognitive function and clinical features following a switch from oral atypical antipsychotics (AAPs) to long‐acting injectable risperidone (LAIR) in patients with schizophrenia. ## Methods Thirty‐six patients with schizophrenia treated with oral

PMH6 The Impact of Long-Acting Injectabl

PMH6 The Impact of Long-Acting Injectable Versus Oral Antipsychotics on Hospitalization Rates in Patients with Schizophrenia: A Systematic Review and Meta-Analysis

✍ M.H. Lafeuille; J. Dean; V. Carter; M.S. Duh; J. Fastenau; R. Dirani; P. Lefebvr 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

A 6-month randomized open-label comparis

A 6-month randomized open-label comparison of continuation of oral atypical antipsychotic therapy or switch to long acting injectable risperidone in patients with bipolar disorder

✍ L. N. Yatham; A. Fallu; C. E. Binder 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB